INFORECERCA: Butlletí Informatiu del Servei de Recerca de l'IMIM
Número: 889
31/01/2025
Projectes
22/02/2025
AGENCIA MUNDIAL ANTIDOPAJE
Development or optimization of analytical tools for the detection of doping substances or methods, growth of the Athlete Biological Passport, the pharmacology of prohibited substances and of drug combinations, evaluation of doping potential and anti-doping testing programs. With this objective, WADA gives high priority to projects with direct and imminent applicability (including human studies if applicable) in the fight against doping in sport.
 
13/03/2025
COMISSIO EUROPEA
The Global Health EDCTP3 Joint Undertaking (Global Health EDCTP3) exists to accelerate the clinical development, evaluation, and implementation of new or improved health technologies for the identification, treatment and prevention of poverty-related and neglected infectious diseases.
 
13/03/2025
PFIZER INC
The intent of this RFP is to support non-interventional Investigator Sponsored Research projects that will advance the understanding of IB6 patterns of expression and clinical outcomes in NSCLC or explore sigvotatug vedotin’s preclinical activity.
 
08/03/2025
ESH - EUROPEAN SOCIETY OF HYPERTENSION
The main purpose of the European Society of Hypertension (ESH) is to provide a stable and organised European platform for scientific exchange in hypertension.

The Servier Research Grant in Hypertension is awarded every 2 years for a research proposal in the field of hypertension and related diseases with a focus on end-organ damage, surrogate markers, and biomarkers.
 
28/03/2025
FUNDACIO SOCIETAT CATALANA DE NEUROLOGIA
Ajudar en el desenvolupament de projectes de recerca originals i inèdits: “Recerca bàsica i clínica”.
 
Borses de viatge
17/10/2025
THE COMPANY OF BIOLOGISTS
Travelling Fellowships of up to £3,000 to graduate students and post-doctoral researchers wishing to make collaborative visits to other laboratories.
 
24/01/2026
FEBS - FEDERATION OF EUROPEAN BIOCHEMICAL SOCIETIES
FEBS Youth Travel Fund (YTF) grants support participation of PhD students and young postdoctoral scientists from the FEBS area in events in the FEBS Advanced Courses programme.
 
Premis
24/03/2025
REAL ACADEMIA DE MEDICINA Y CIRUGÍA DEL PRINCIPADO DE ASTURIAS
Premi Internacional Hipòcrates d'investigació mèdica sobre Nutrició Humana, destinat a honrar als científics dedicats a esclarir les qüestions relacionades amb aquesta important especialitat de la Medicina.
 
Recursos Humans
22/02/2025
CRI - CANCER RESEARCH INSTITUTE
The CRI Irvington Postdoctoral Fellowship Program supports qualified young scientists at leading universities and research centers around the world who wish to receive training in fundamental immunology or cancer immunology.
 
27/03/2025
FUNDACIÓN CAROLINA
L'objectiu de les beques, igual que en convocatòries passades, és generar valor social a l'entorn de les persones beneficiàries per contribuir a una resposta justa davant els reptes actuals de la “triple transició”, digital, ecològica i social.
 
 
 
Informació últil
 
 
Banner-convocatories-tancament-02
Projectes
22/02/2025
AGENCIA MUNDIAL ANTIDOPAJE
Development or optimization of analytical tools for the detection of doping substances or methods, growth of the Athlete Biological Passport, the pharmacology of prohibited substances and of drug combinations, evaluation of doping potential and anti-doping testing programs. With this objective, WADA gives high priority to projects with direct and imminent applicability (including human studies if applicable) in the fight against doping in sport.
 
27/02/2025
COMISSIO EUROPEA
The aim of the call is to facilitate multinational, collaborative research projects that will address critical translational and clinical questions using interdisciplinary approaches to improve the knowledge about the neuroscience of pain, bearing the potential to improve the lives of the people affected.
 
20/02/2025
AGAUR - AGENCIA DE GESTIO AJUTS UNIVERSITARIS DE RECERCA
Concedir ajuts en règim de concurrència competitiva a les universitats i la resta dels agents del sistema de recerca, desenvolupament i innovació a Catalunya per desenvolupar projectes amb impacte social orientats a l'abordatge de reptes en salut mental i benestar emocional, de les universitats i la resta dels agents del sistema de recerca, desenvolupament i innovació de Catalunya, amb la participació indispensable d'entitats de la societat civil, ens locals o altres de caràcter públic del territori.
 
20/02/2025
AGAUR - AGENCIA DE GESTIO AJUTS UNIVERSITARIS DE RECERCA
Concedir ajuts en règim de concurrència competitiva a les universitats i la resta dels agents del sistema de recerca, desenvolupament i innovació a Catalunya per desenvolupar projectes amb impacte social a través del coneixement orientats a l'abordatge i a la millora dels reptes globals, emmarcats en els Objectius de Desenvolupament Sostenible de l'Agenda 2030, i enfocats al territori o a la comunitat i cultura universitàries del sistema de recerca i coneixement català, amb la participació indispensable d'entitats de la societat civil, ens locals o altres entitats de caràcter públic del territori.
 
11/02/2025
COMISSIO EUROPEA
The objective is to support innovative research in pharmacogenomic strategies for personalized medicine, includes identifying and validating pharmacogenomic markers, optimizing treatment outcomes through multi-omics data, and ensuring personalized patient care.
 
27/02/2025
ISCIII - INSTITUTO DE SALUD CARLOS III
Fomentar la investigació clínica independent, amb medicaments d'ús humà i / o teràpies avançades, mitjançant el finançament de projectes no promoguts per la indústria farmacèutica.
 
01/03/2025
FONDATION JEROME LEJEUNE
The Fondation Jérôme Lejeune (FJL) initiates, develops and finances fundamental, translational and clinical research programs in Down syndrome and other intellectual disabilities of genetic origin with early onset.
 
26/02/2025
FUNDACIÓN MUTUA MADRILEÑA
En la línia de les anteriors convocatòries, vol continuar donant més rellevància a la investigació clínica d'excel·lència.
 
21/02/2025
FDM - FUNDACIÓN DOMINGO MARTÍNEZ
Es convoquen anualment ajuts a la Investigació en dues Àrees: Materials i Biomedicina / Salut, àrees en què es desenvolupen i / o apliquen els productes objecte de les activitats d'AMSA (gasos industrials i medicinals).
 
21/02/2025
SOCIEDAD ESPAÑOLA DE LA RODILLA (SEROD)
Dues beques: un Projecte de Recerca (Beca Sènior) i un Projecte d'Iniciació a la Recerca (Beca Junior)
 
24/02/2025
Lung Cancer Research Foundation
This grant mechanism will focus on the science behind HER2 alterations as oncogenic drivers of malignancy and/or the development of novel therapeutic approaches for patients with tumors harboring HER2 mutations and/or other HER2 alterations.
 
24/02/2025
Lung Cancer Research Foundation
Given the significance and need for early detection of lung cancer and advancements in molecular screening, LCRF continues to offer a funding mechanism to support research projects that facilitate or advance the understanding and characterization of approaches for early detection of lung cancer. Work supported through this mechanism addresses important questions in non-small cell and small cell lung cancer.
 
24/02/2025
Lung Cancer Research Foundation
In 2025, in partnership with leading patient advocacy organizations, this grant mechanism will focus on furthering the understanding of the development, prevention, and therapy of resistance by supporting projects that seek to identify, characterize, treat or prevent resistance to lung cancer therapies.
 
24/02/2025
Lung Cancer Research Foundation
The goal of the LCRF Leading Edge Research Grant Program is to fund innovative projects across the full spectrum of basic, translational, clinical, epidemiological, health services, early detection, disparities, and social determinants of health research.
 
24/02/2025
GILEAD COLORADO - GILEAD SCIENCES INC
The program is designed to support pre-clinical and clinical research in the field of Oncology Solid Tumors in Australia, Canada, and Europe. For the 2025 cycle, the program will focus on Breast, Upper GI (esophageal, gastric, & gastroesophageal junction cancer), and Lung cancer.
 
21/02/2025
FOUNDATION FOR PRADER-WILLI RESEARCH
FPWR is particularly interested in supporting projects that will lead to new treatments to alleviate the symptoms associated with PWS.
 
28/02/2025
COMISSIO EUROPEA
The ERA4Health Partnership's "InterHeart" Joint Transnational Call (JTC) aims to support research projects that investigate the complex relationship between cardiovascular disorders and other diseases, as well as the impact of their treatments on the cardiovascular system. The call encourages transnational research collaborations to develop a deeper understanding of how different organ systems interact in both healthy and diseased states, with a particular focus on the cardiovascular system. Key principles of this grant include promoting responsible research and innovation (RRI), fostering international collaboration, and prioritising patient-centric approaches to advance knowledge, improve diagnostics, and develop more effective prevention and treatment strategies for cardiovascular diseases and related conditions.
 
13/02/2025
FUNDACIO LA CAIXA
The ”la Caixa” Foundation (hereinafter “LCF”) is supporting the Iberian ecosystem of biomedical innovation by helping to successfully transfer scientific knowledge to society through products, services, devices and businesses.
 
21/02/2025
FUNDACIÓN SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA PEDIÁTRICA
L'objectiu de la Beca és donar suport al desenvolupament d'un projecte de Cooperació al Desenvolupament, en l'àrea de l'Endocrinologia Pediàtrica
 
21/02/2025
FUNDACIÓN SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA PEDIÁTRICA
Promoure i incentivar projectes de recerca clínica a l'àrea de la Endocrinologia Pediàtrica. Els estudis es desenvoluparan a Espanya i seran multicèntrics col·laboratius. El projecte pot estar ja en curs o pendent d'iniciar-se en l'any de la convocatòria.
 
21/02/2025
LABORATORIOS GRIFOLS S.A.
The objectives of the ALTA Awards are to identify and engage investigators (both physicians and scientists) who are early in their careers in a longstanding commitment to investigating Alpha-1 Antitrypsin Deficiency (AATD) and to strengthen the network between scientists and clinicians working in the field of AATD.
 
Borses de viatge
13/02/2025
FUNDACIÓN RAFAEL DEL PINO
El Programa de Beques d'Excel·lència Rafael del Pino té com a objectiu contribuir a la formació dels dirigents espanyols, al foment de l'esperit i l'activitat emprenedora a Espanya i a la investigació i la difusió del coneixement.
 
21/02/2025
EUROPEAN SOCIETY OF ENDOCRINOLOGY
ESE offers 100 Meeting Grants worth as a contribution towards the total cost of attending an ESE event in person. These include:
  • Joint Congress of ESPE and ESE 2025/ECE Deadline 19 March 2025
  • Meeting grant for AME (Associazione Medici Endocrinologi) in Association with ESE - 2025 Early Careers Update in Clinical Endocrinology. Deadline 28 February 2025
  •  
    21/02/2025
    THE COMPANY OF BIOLOGISTS
    DMM Conference Travel Grants are aimed at early-career researchers wanting to attend scientific meetings, conferences, workshops and courses relating to the areas of research covered by the journal.
     
    23/02/2025
    B.I.F. - BOEHRINGER INGELHEIM ESPAÑA SA
    For junior researchers pursuing experimental projects in basic biomedical research and who wish to pursue a short-term research stay or attend a practical course of up to 3 months.
     
    Premis
    10/02/2025
    FUNDACIÓN LILLY
    La FUNDACIÓ LILLY convoca els Premis Fundació Lilly d'Investigació Biomèdica Preclínica i Clínica 2025, per a investigadors que hagin contribuït de forma significativa al desenvolupament de la Biomedicina i les Ciències de la Salut a Espanya, i mantinguin una activitat de reconegut nivell científic.
     
    21/02/2025
    FUNDACIÓN SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA PEDIÁTRICA
    L'objectiu d'aquests premis és promoure i incentivar els treballs de recerca en matèries relacionades amb l'endocrinologia pediàtrica
     
    Recursos Humans
    26/02/2025
    ISCIII - INSTITUTO DE SALUD CARLOS III
    L'objecte d'aquesta actuació és la contractació de personal doctor titulat recentment en el camp de les ciències i tecnologies de la salut, per perfeccionar la seva formació.
     
    26/02/2025
    ISCIII - INSTITUTO DE SALUD CARLOS III
    L'objecte d'aquesta actuació és la contractació de professionals, exclusivament en les entitats sanitàries de titularitat pública, amb activitat clínic assistencial, que hagin superat la FSE, per al desenvolupament d'un pla de formació en investigació en ciències i tecnologies de la salut.
     
    11/02/2025
    FUNDACIO LA CAIXA
    The call for applications is intended for the pursuit of a doctoral degree in all areas of knowledge. Applicants must meet the admission requirements for a doctoral programme, fulfil the mobility criteria detailed in section 4.5, and not have previously begun any doctoral studies.
    Fellows should start at the host institutions between September and November 2025. Nevertheless, in duly justified cases, the ”la Caixa” Foundation may allow this to be delayed until January 31 2026.
     
    22/02/2025
    CRI - CANCER RESEARCH INSTITUTE
    The CRI Irvington Postdoctoral Fellowship Program supports qualified young scientists at leading universities and research centers around the world who wish to receive training in fundamental immunology or cancer immunology.
     
    09/02/2025
    FOUNDATION FOR RESEARCH IN RHEUMATOLOGY
    FOREUM is committed to promote the best talents in the field of rheumatic and musculoskeletal diseases (RMD). Consistent with these goals, FOREUM issues a new call that aims to fund excellent young researchers promoting innovative ideas and supporting high quality research projects covering basic and clinical science projects related to RMDs.
     
    25/02/2025
    ICREA - INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS (ICREA)
    ICREA opens 20 senior research positions in the following areas:
  • Experimental Sciences & Mathematics
  • Engineering Sciences
  •  
    10/02/2025
    EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES (EFSD)
    The Programme aims to identify promising and innovative young researchers in the field of diabetes.
     
    10/02/2025
    EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES (EFSD)
    The objective of the EFSD/Lilly Young Investigator Research Awards is to encourage innovative research in the fields of diabetes and its complications, and to promote excellence in medical education. Applicants should have demonstrated their ability in the field of diabetes research.
     
    21/02/2025
    FUNDACIÓN SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA PEDIÁTRICA
    L'objectiu de la Beca és donar suport al desenvolupament d'un projecte de recerca clínica, a realitzar en alguna de les dues modalitats:
  • Col·laboració amb un grup d´Endocrinologia Pediàtrica d'un centre diferent del lloc de treball propi
  • Fer una estada en una altra àrea de coneixement vinculada clínicament a Endocrinologia Pediàtrica, podent pertànyer l'àrea al mateix centre hospitalari o un altre.
  •  
    21/02/2025
    FUNDACIÓN SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA PEDIÁTRICA
    L'objectiu de la beca és donar suport al desenvolupament d'un projecte d'investigació bàsica a un centre de reconegut prestigi en matèries relacionades amb l'Endocrinologia Pediàtrica.
     
     
     
     
    Articles
     
    Cacciaglia R*, Shekari M, Salvadó G, Milà M, Falcón C, Sánchez-Benavides G, Minguillón C, Fauria K, Grau-Rivera O, Molinuevo JL, Blennow K, Zetterberg H, Quevenco FC, Suarez-Calvet M, Gispert JD, ALFA Study. The CSF p-tau/β-amyloid 42 ratio correlates with brain structure and fibrillary β-amyloid deposition in cognitively unimpaired individuals at the earliest stages of pre-clinical Alzheimer's disease. Brain Commun . 2025; 7(1): fcae451 (Acceptat).
     
    Canals L, Cañas A*, Huesa G, Suarez-Calvet M, Milà M, Arenaza-Urquijo EM, Cirillo D, Dimech AS, Iulita MF, Martinkova JN, Tartaglia MC, Quevenco FC, Chadha AS, Sánchez-Benavides G, Minguillón C, Ferretti MT, Fauria K*, Brugulat-Serrat A*, ALFA Study. Impact of gender on the willingness to participate in clinical trials and undergo related procedures in individuals from an Alzheimer's prevention research cohort. Alzheimers Res. Ther. 2024; 16(1): 263.
     
    Hurtado P, Garcia-Orellana M*, Martinez-Simon A, Pujol-Fontrodona G, Méndez E, Doménech Asensi, Pajares A, López-Gómez A, Valencia L, Colomina MJ, Fernández-Candil JL, Grupo de trabajo de Neurociencias y Hemostasia, Medicina Transfusional y Fluidoterapia de la Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor (SEDAR). Perioperative transfusion management in craniotomies: A national survey, a starting point for the evaluation of improvements in health care. Rev Esp Anestesiol Reanim 2024: (en Premsa).
     
    Fernández-Pérez I, Vallverdú-Prats M, Rey L, Steinhauer EG, Ois A, Cuadrado E, Rodríguez Campello A, Suarez-Perez A, Macias-Gómez A, Soriano Tàrrga C, Purroy F, Arqué G, Tur S, Cañellas G, Vives-Bauza C, Segura T, Serrano-Heras G, Lazcano Uxue U, Jiménez J*, Jiménez Conde J*. Circulating miRNAs Associated With 3-Month Outcome in Patients With Acute Ischemic Stroke. Neurology 2025; 104(1): e210085.
     
    Rey HG, Panagiotaropoulos TI, Gutierrez L, Chaure FJ, Nasimbera A, Cordisco S, Nishida F, Valentin A, Alarcon G, Richardson MP, Kochen S, Quian-Quiroga RC*. Lack of context modulation in human single neuron responses in the medial temporal lobe. Cell Rep 2025; 44: (en Premsa).
     
    Fabbri L, Robinson O, Basagaña X, Chatzi L, Gražulevičienė R, Guxens M, Kadawathagedara M, Sakhi AK, Maitre L, McEachan R, Philippat C, Pozo ÓJ, Thomsen C, Wright J, Yang T, Vrijheid M*. Childhood exposure to non-persistent endocrine disruptors, glucocorticosteroids, and attentional function: A cross-sectional study based on the parametric g-formula. Environ Res 2025; 264(Pt 2): 120413.
     
    Alvarado MN, Solano A, Marsico S, Nuñez A, Cumpli MC, Sainz M, Maiques J, Barreiro E*. Clinical Implications of Functional Imaging in the Assessment of Bronchiectasis-Associated Sarcopenia. Arch Bronconeumol 2024: (en Premsa).
     
    Catalan A*, Salazar-de Pablo G, Aymerich C, Guinart D, Goena J, Madaria L, Pacho M, Alameda L, Garrido-Torres N, Pedruzo B, Rubio JM, González-Torres MA, Fusar-Poli P, Correll CU. "Short" Versus "Long" Duration of Untreated Psychosis in People with First-Episode Psychosis: A Systematic Review and Meta-Analysis of Baseline Status and Follow-Up Outcomes. Schizophrenia Bull 2024: (en Premsa).
     
    Temprano-Sagrera G, Peypoch O, Soto B, Dilmé J, Calsina L, Davtian D, De La Rosa M, Nieto L, Brown A, Escudero JR, Viñuela A, Camacho M, Sabater-Lleal M*. Differential Expression Analyses on Human Aortic Tissue Reveal Novel Genes and Pathways Associated With Abdominal Aortic Aneurysm Onset and Progression. J Am Heart Assoc 2024; 13(24): e036082.
     
    Hernando J, Castañer O*, Fitó Colomer M. Atherogenic low-density lipoprotein and cardiovascular risk. Curr Opin Lipidol 2025; 36(1): 8-13.
     
    Buongiorno M*, Sánchez-Benavides G, Marzal-Espí C, Giraldo DM, Krupinski J, Cullell N, Grau-Rivera O, Suarez-Calvet M, Gispert JD, de la Sierra A, Alzheimer's Disease Neuroimaging Initiative and the European Prevention of Alzheimer's Disease (EPAD) Consortium. Blood-brain barrier permeable β-blockers association with Alzheimer's disease cerebrospinal fluid biomarkers levels in non-demented individuals. J Alzheimers Dis 2024; 102(4): 975-980.
     
    Domínguez-López I, Lamuela-Raventos RM, Razquin C, Arancibia-Riveros C, Galkina P, Salas Salvadó J, Alonso Gómez A.M, Fitó Colomer M, Fiol M, Lapetra J, Gómez Gracia E, Sorli JV, Ruiz Canela M, Castañer O, Liang L, Serra Majem LL, Hu FB, Ros E, Martínez González M.A*, Estruch R*. Urinary tartaric acid as a biomarker of wine consumption and cardiovascular risk: the PREDIMED trial. Eur Heart J 2025; 46(2): 161-172.
     
    Pou-Bordoy J, Leiva A*, Albendín-Ariza MJ, Elosua R, Rigo F, Romaguera D, Salas Salvadó J, Babio N, Martínez González M.A, Toledo E, Fitó Colomer M, Arós F, Estruch R, Fiol M. Major abnormalities of the electrocardiogram and cardiovascular risk in a medium and high-risk Mediterranean population. Med Clin (Barc) 2024: (en Premsa).
     
    Anastasaki M*, Papadakis S, Gergianaki IN, Papastamatiou L, Aligizakis E, Grillaki N, Boutzoukaki E, Sivaropoulos N, Anastasiou F, Mendive J, De Juan Asenjo C, Hernández-Ibáñez R, Martínez-Escudé A, García-Retortillo M, Koek G, Heyens L, Muris J, Lionis CD. Development and pilot evaluation of an evidence-based algorithm for MASLD (formerly NAFLD) management in primary care in Europe. Front Med (Lausanne) . 2025; 11: 1383112 (Acceptat).
     
    Bigas A*, Kartha GM. Making blood from iPSCs: Reaching for the most sought-after prize. Cell Stem Cell 2025; 31(12): 1730-1731.
     
    Coll S, Hernández D, Bressan C, Ramírez-Llanelis R, Monfort N, Aldea-Perona A, Ventura R*. Impact of Repeated Glucocorticoid Oral Administration on the Urinary Steroid Profile. Drug Test Anal 2025: (en Premsa).
     
    Rubio-Rivas M*, Mora-Luján J, Montero-Sáez A, Martín D, Giner-Galvañ V, Maestro-de la Calle G, Taboada-Martínez ML, Muiño-Míguez A, Lumbreras-Bermejo C, Antón-Santos JM, SEMI-COVID-19 Network. Which one is a better predictor of prognosis in COVID-19: analytical biomarkers or PaO2/FiO2?. Rev Clin Esp 2024: (en Premsa).
     
    Ribas Y*, Muñoz-Duyos A, Franquet M, Guerreiro I, Perau J, Porras O, Rodríguez D, Rojo J, Ramírez L, Rubio M, Marinello F, JIimenez M, Romero C. Enhancing support for patients with low anterior resection syndrome: insights and educational resources from the LARSCAT project. Int J Colorect Dis 2025; 39(1): 196.
     
    Vitulo P*, Piccari L, Wort SJ, Shlobin OA, Kovacs G, Vizza CD, Hassoun PM, Olschewski H, Girgis RE, Nikkho SM, Nathan SD. Screening and diagnosis of pulmonary hypertension associated with chronic lung disease (PH-CLD): A consensus statement from the pulmonary vascular research institute's innovative drug development initiative-group 3 pulmonary hypertension. Pulm Circ . 2024; 14(4): e70005 (Acceptat).
     
    Pappalettere CC, Llagostera-Martin M, Vime-Jubany J, Cainzos-Achirica M*. Cardiovascular disease in South Asian immigrants facing adverse socioeconomic circumstances: challenges and opportunities for enhanced management. Curr Opin Cardiol 2025; 40(1): 42-49.
     
    Zhou XD, Chen QF, Yang W, Zuluaga M, Targher G, Byrne CD, Valenti L, Luo F, Katsouras CS, Thaher O, Misra A, Ataya K, Oviedo RJ, Pik-shan Kong A, Alswat K, Lonardo A, Wong YJ, Abu-Abeid A, Al-Momani H, Ali A, Molina GA, Szepietowski O, Jumaev NA, Kızılkaya MC, Viveiros O, Toro-Huamanchumo CJ, Kok KYY, Ospanov O, Abbas SI, Robertson AG, Fouad Y, Mantzoros CS, Zhang H, Méndez-Sánchez N, Sookoian S, Chan WK, Treeprasertsuk S, Adams L, Ocama P, Ryan JD, Perera N, Sharara AI, Al-Busafi SA, Opio CK, Garcia M, Lim-Loo MC, Ruiz-Úcar E, Prasad A, Casajoana Badia A, Abdelbaki TN, Zheng MH*. Erratum: Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021. EClinicalMedicine . 2025; 78: 102958 (Acceptat).
     
    Suarez-Perez A, Macias-Gómez A, Fernández-Pérez I, Vallverdú-Prats M, Cuadrado E, Steinhauer EG, Campanale C, Guisado D, Rodríguez Campello A, Jiménez J*, Jiménez Conde J, Ois A. Epigenetic age and long-term cancer risk following a stroke. Genome Med 2024; 16(1): 135.
     
    Starace M, Cedirian S, Rapparini L, Pileri A, Carrera C, Giavedoni P, Alonso-de Leon MT, Kraehenbuehl L, Elshot YS, Apalla Z, Papegeorgiou C, Nikolaou V, Radevic T, Lengyel Z, Sollena P, Peris K, Rossi E, Fattore D, Koumaki D, Boada A, Forsea AM, Segura S, Freites-Martinez A, Riganti J, Avitan-Hersh E, Saffuri N, Peuvrel L, Dezoteux F, Piraccini BM, Sibaud V. Immune Checkpoint Inhibitor-Induced Vitiligo-Like Depigmentation. JAMA Dermatol 2024: (en Premsa).
     
     
    Tel: 93 316 04 00
    Doctor Aiguader, 88
    08003 Barcelona
    Seguiu-nos a:
    Twitter
    Youtube
    En compliment de la Llei 34/2002, de Serveis de la Societat de la Informació i de Comerç Electrònic, aquest correu li hem enviat a partir de les dades de contacte que vostè ens ha facilitat. Si vostè no desitja rebre més comunicats, pot donar-se de baixa dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es) tot indicant la paraula “baixa base de dades” a l’assumpte.
    Li recordem que podrà exercir els drets d’accés, rectificació, cancel·lació i oposició dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es).